Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
NANO-X IMAGING LTD (Nanox) (NASDAQ: NNOX) is a medical imaging technology company that combines imaging hardware, AI-based software, cloud infrastructure, and teleradiology services. The Nanox news feed on this page aggregates company press releases and market updates so readers can follow how Nanox advances its imaging platform, commercial strategy, and capital markets activity over time.
Nanox’s recent news highlights its Nanox.ARC and Nanox.ARC X multi-source digital tomosynthesis systems, including CE Mark certification for Nanox.ARC in Europe and FDA 510(k) clearance for Nanox.ARC X for general use in multiple clinical indications. Articles also cover distribution agreements and collaborations with partners in countries such as France, the Czech Republic, Greece, Romania, Serbia, Montenegro, and Bosnia and Herzegovina, reflecting efforts to expand clinical and commercial deployment of its imaging solutions.
Another key news theme is the growth of Nanox.AI and its imaging analytics portfolio. Press releases describe AI algorithms that analyze routine CT scans for early signs associated with chronic diseases and bone health solutions such as HealthVCF and HealthOST, which have been included in an Early Value Assessment by the UK National Institute for Health and Care Excellence. Updates also discuss acquisitions like VasoHealthcare IT, intended to support deployment of AI solutions across U.S. healthcare facilities.
Investors and analysts can also find financial results announcements, guidance updates, and details of registered direct offerings and other financings, as reported in Nanox’s press releases and related SEC filings. Together, these news items provide insight into Nanox’s commercialization progress, clinical collaborations, AI development roadmap, and capital strategy. Bookmark this page to access an organized stream of Nanox news, from product and partnership updates to financial and regulatory disclosures.
Nanox (NASDAQ:NNOX) announced that Nanox Impact signed a U.S. distribution agreement with Radiology Oncology Systems to roll out the Nanox.ARC across U.S. clinical settings. The Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system intended to expand 3D imaging access with lower dose and cost.
The agreement leverages Radiology Oncology Systems’ distribution and service network to support planned deployments in oncology-adjacent and other clinical environments.
Nano-X Imaging (NASDAQ:NNOX) signed a commercial agreement with Howard Technology Solutions to deploy 300 Nanox.ARC systems over three years, including 60 systems in year one. The Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system said to offer 3D imaging at lower cost and reduced radiation versus traditional CT.
Howard will market and deploy systems across its national healthcare and public sector channels, targeting underserved customer segments and leveraging its nationwide sales and service infrastructure.
NANO-X IMAGING (NASDAQ: NNOX) reported $3.7M revenue for Q4 2025 and a $33.4M net loss, driven largely by a $17.5M impairment tied to a South Korea manufacturing restructuring. The company closed the Nanox Health IT acquisition, signed U.S. distribution agreements (including 300 systems with Howard) and has ~36 systems in deployment.
Guy Nathanzon is appointed CFO effective August 1, 2026; restructuring charges total approximately $18.0M.
Nanox (Nasdaq: NNOX) announced on April 16, 2026 that its Nanox.ARC X 3D digital tomosynthesis system won the Red Dot Award: Product Design 2026. The award recognizes the system's compact, single-unit design, plug-and-play installation, and potential for broader clinical deployment. The device will be featured in Red Dot exhibitions and yearbook, increasing global visibility for the design created with TAGA Innovations.
The company emphasized the product's reduced footprint versus CT, simplified workflow, and remote upgrade capability as enablers for use in smaller imaging centers and outpatient clinics.
Nanox (Nasdaq: NNOX) announced a clinical collaboration with Meir Medical Center on April 14, 2026 to evaluate the Nanox.ARC multisource digital tomosynthesis system for emergency orthopedic imaging.
The IRB-approved study will compare Nanox.ARC to conventional radiography and CT for fracture detection, focusing on diagnostic confidence, speed, and lower radiation dose to support broader clinical adoption.
Nano X Imaging (NASDAQ: NNOX) announced that Nanox Impact signed a distribution agreement with Digital X-Ray Imaging to deploy the Nanox.ARC across DXI’s regional network in Arkansas. This marks Nanox’s fourth U.S. distribution collaboration in 2026 and aims to expand access to FDA-cleared digital tomosynthesis with local installation and service support.
DXI brings 30+ years of regional experience and a statewide team of factory-trained service engineers to support installations and ongoing clinical evaluations.
Nano-X Imaging (Nasdaq: NNOX) will report fourth quarter 2025 financial results before market open on Monday, April 20, 2026. A conference call and live webcast with CEO Erez Meltzer and CFO Ran Daniel begins at 8:30 a.m. ET to review results and provide a business update.
Registration and webcast links will be posted in the Investor Relations Events and Presentations section for interested parties.
Nanox (NASDAQ: NNOX) announced a U.S. distribution agreement with Integrity Medical Service to sell, implement and service the Nanox.ARC system across Colorado, Wyoming and western Kansas and Nebraska.
The agreement targets deployment of 4 systems in Year 1 and 12 systems in Year 2, and leverages Integrity’s field service engineers to support outpatient imaging adoption.
Nano-X Imaging (NASDAQ: NNOX) announced a U.S. distribution agreement with Elite Surgical Technologies to deploy the Nanox.ARC multisource digital tomosynthesis system across Ohio, Indiana, Michigan, Pittsburgh and West Virginia.
According to the company, the agreement targets orthopedic and post-surgical imaging, with a minimum of five systems in year one and ten in year two, subject to market conditions and customer adoption.
Nanox (NASDAQ: NNOX) announced on March 3, 2026 that Nanox Impact signed a distribution agreement with Imperial Imaging Technology to deploy the Nanox.ARC multisource digital tomosynthesis system across Georgia, Alabama, Tennessee, North Carolina, South Carolina, and Northern Florida.
Imperial will handle marketing, demos, clinical evaluations, installations, and customer support for orthopedic and musculoskeletal practices. According to the company, Nanox.ARC DTS imaging is reimbursable under an existing CPT code and requires no pre-authorization.